Screener
DiaMedica Therapeutics DMAC Q1 2025 earnings
Reported May 13, 2025 · After market close
EPS-$0.18In line
EPS estimate-$0.18
Next report
Nov 11, 2026 (in 2 months)Revenue estimate$13.5M
EPS estimate-$0.20
Versus estimates
Diluted EPS
FAQ
- When did DiaMedica Therapeutics report Q1 2025 earnings?
- DiaMedica Therapeutics (DMAC) reported Q1 2025 earnings on May 13, 2025 after market close.
- What were DiaMedica Therapeutics's Q1 2025 revenue and EPS?
- DiaMedica Therapeutics reported eps of $-0.18 for Q1 2025.
- Did DiaMedica Therapeutics beat estimates in Q1 2025?
- EPS beat the consensus estimate of $-0.18 by $0.00.
- How did DiaMedica Therapeutics's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 28.6% from $-0.14.
- Where can I find DiaMedica Therapeutics's Q1 2025 SEC filings?
- You can read the 8-K earnings release (0001437749-25-016487) and the 10-Q periodic report (0001437749-25-016488) directly on SEC EDGAR. The filing index links above go to sec.gov.
